AGIO
AGIOS PHARMACEUTICALS, INC.
+1.01 (+3.07%)33.96USD177K成交股數2.0B市值–本益比(近四季)20.6股價營收比+259.3%營收年增(近四季)2026-10-29下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 2 · 1.1M · 1 |
| 其中 10b5-1 計畫賣出 | 2 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 2.3M |
| 近 180 天 淨額 | −2.3M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 | 08-06 | Gheuens Sarah | Chief Medical Officer | S 公開市場賣出(10b5-1) | 30.0K | 30.48 | 914K | 54.6K | SEC |
| 2026-07-08 | 07-10 | Backstrom Jay T. | Director | A 獲配股票 | 1.4K | – | – | 1.4K | SEC |
| 2026-07-01 | 07-02 | Gheuens Sarah | Chief Medical Officer | S 公開市場賣出(10b5-1) | 4.0K | 37.56 | 151K | 84.6K | SEC |
| 2026-07-01 | 07-02 | Gheuens Sarah | Chief Medical Officer | M 選擇權執行 | 8.4K | – | – | 88.7K | SEC |
| 2026-06-18 | 06-23 | Ballal Rahul D. | Director | M 選擇權執行 | 2.8K | – | – | 15.2K | SEC |
| 2026-06-18 | 06-23 | Owen Adams Catherine | Director | M 選擇權執行 | 2.8K | – | – | 10.9K | SEC |
| 2026-06-18 | 06-23 | Smith Cynthia | Director | M 選擇權執行 | 2.8K | – | – | 15.2K | SEC |
| 2026-06-18 | 06-23 | CAPELLO JEFFREY D | Director | M 選擇權執行 | 2.8K | – | – | 10.9K | SEC |
| 2026-06-18 | 06-23 | Foster-Cheek Kaye I | Director | M 選擇權執行 | 2.8K | – | – | 10.3K | SEC |
| 2026-06-18 | 06-23 | Scadden David | Director | M 選擇權執行 | 2.8K | – | – | 20.4K | SEC |
| 2026-06-18 | 06-23 | FOUSE JACQUALYN A | Director | M 選擇權執行 | 2.8K | – | – | 154K | SEC |
| 2026-06-18 | 06-23 | Ho Maykin | Director | M 選擇權執行 | 2.8K | – | – | 19.8K | SEC |
| 2026-06-13 | 06-16 | Owen Adams Catherine | Director | M 選擇權執行 | 2.0K | – | – | 8.0K | SEC |
| 2026-06-13 | 06-16 | CAPELLO JEFFREY D | Director | M 選擇權執行 | 2.0K | – | – | 8.0K | SEC |
| 2026-04-02 | 04-06 | Jones Cecilia | Chief Financial Officer | S 公開市場賣出(10b5-1) | 3.1K | 34.71 | 109K | 55.0K | SEC |
| 2026-04-02 | 04-06 | Burns James William | Chief Legal Officer | M 選擇權執行 | 8.5K | – | – | 52.6K | SEC |
| 2026-04-02 | 04-06 | Milanova Tsveta | Chief Commercial Officer | M 選擇權執行 | 8.5K | – | – | 50.1K | SEC |
| 2026-04-02 | 04-06 | Gheuens Sarah | Chief Medical Officer | M 選擇權執行 | 8.5K | – | – | 83.2K | SEC |
| 2026-04-02 | 04-06 | Milanova Tsveta | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 3.3K | 34.71 | 113K | 46.8K | SEC |
| 2026-04-02 | 04-06 | Gheuens Sarah | Chief Medical Officer | S 公開市場賣出(10b5-1) | 2.9K | 34.71 | 102K | 80.3K | SEC |
| 2026-04-02 | 04-06 | Viswanadhan Krishnan | Chief Corp Dev & Strategy | S 公開市場賣出(10b5-1) | 3.0K | 34.71 | 103K | 10.3K | SEC |
| 2026-04-02 | 04-06 | Jones Cecilia | Chief Financial Officer | M 選擇權執行 | 8.5K | – | – | 58.1K | SEC |
| 2026-04-02 | 04-06 | Goff Brian | Chief Executive Officer | S 公開市場賣出(10b5-1) | 6.6K | 34.71 | 229K | 185K | SEC |
| 2026-04-02 | 04-06 | Viswanadhan Krishnan | Chief Corp Dev & Strategy | M 選擇權執行 | 8.1K | – | – | 13.2K | SEC |
| 2026-04-02 | 04-06 | Goff Brian | Chief Executive Officer | M 選擇權執行 | 25.5K | – | – | 190K | SEC |
| 2026-04-02 | 04-06 | Burns James William | Chief Legal Officer | S 公開市場賣出(10b5-1) | 3.3K | 34.71 | 114K | 49.3K | SEC |
| 2026-04-02 | 04-06 | Goff Brian | Chief Executive Officer | S 公開市場賣出(10b5-1) | 12.5K | 34.71 | 433K | 178K | SEC |
| 2026-04-02 | 04-06 | Goff Brian | Chief Executive Officer | M 選擇權執行 | 13.5K | – | – | 191K | SEC |
| 2026-03-05 | 03-09 | Viswanadhan Krishnan | Chief Corp Dev & Strategy | S 公開市場賣出(10b5-1) | 3.0K | 27.80 | 82K | 5.1K | SEC |
| 2026-03-05 | 03-09 | Viswanadhan Krishnan | Chief Corp Dev & Strategy | M 選擇權執行 | 8.1K | – | – | 8.1K | SEC |
| 2026-03-03 | 03-05 | Washburn Theodore James Jr. | Principal Accounting Officer | S 公開市場賣出 | 5.3K | 28.88 | 152K | 868 | SEC |
| 2026-03-02 | 03-03 | Burns James William | Chief Legal Officer | M 選擇權執行 | 3.9K | – | – | 45.2K | SEC |
| 2026-03-02 | 03-03 | Burns James William | Chief Legal Officer | S 公開市場賣出(10b5-1) | 1.2K | 28.96 | 34K | 41.3K | SEC |
| 2026-03-02 | 03-03 | Burns James William | Chief Legal Officer | M 選擇權執行 | 4.0K | – | – | 42.5K | SEC |
| 2026-03-02 | 03-03 | Burns James William | Chief Legal Officer | M 選擇權執行 | 5.7K | – | – | 40.2K | SEC |
| 2026-03-02 | 03-03 | Burns James William | Chief Legal Officer | S 公開市場賣出(10b5-1) | 1.2K | 28.96 | 34K | 34.5K | SEC |
| 2026-03-02 | 03-03 | Burns James William | Chief Legal Officer | M 選擇權執行 | 4.0K | – | – | 35.7K | SEC |
| 2026-03-02 | 03-03 | Gheuens Sarah | Chief Medical Officer | M 選擇權執行 | 4.0K | – | – | 75.6K | SEC |
| 2026-03-02 | 03-03 | Gheuens Sarah | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.7K | 28.96 | 49K | 71.6K | SEC |
| 2026-03-02 | 03-03 | Gheuens Sarah | Chief Medical Officer | M 選擇權執行 | 5.7K | – | – | 73.3K | SEC |
| 2026-03-02 | 03-03 | Gheuens Sarah | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.2K | 28.96 | 34K | 67.6K | SEC |
| 2026-03-02 | 03-03 | Gheuens Sarah | Chief Medical Officer | M 選擇權執行 | 4.0K | – | – | 68.8K | SEC |
| 2026-03-02 | 03-03 | Jones Cecilia | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.6K | 28.96 | 46K | 49.3K | SEC |
| 2026-03-02 | 03-03 | Jones Cecilia | Chief Financial Officer | M 選擇權執行 | 5.3K | – | – | 50.9K | SEC |
| 2026-03-02 | 03-03 | Jones Cecilia | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.2K | 28.96 | 34K | 45.6K | SEC |
| 2026-03-02 | 03-03 | Jones Cecilia | Chief Financial Officer | M 選擇權執行 | 4.0K | – | – | 46.8K | SEC |
| 2026-03-02 | 03-03 | Jones Cecilia | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.7K | 28.96 | 49K | 42.8K | SEC |
| 2026-03-02 | 03-03 | Jones Cecilia | Chief Financial Officer | M 選擇權執行 | 5.7K | – | – | 44.5K | SEC |
| 2026-03-02 | 03-03 | Jones Cecilia | Chief Financial Officer | S 公開市場賣出(10b5-1) | 594 | 28.96 | 17K | 38.8K | SEC |
| 2026-03-02 | 03-03 | Jones Cecilia | Chief Financial Officer | M 選擇權執行 | 2.0K | – | – | 39.4K | SEC |
| 2026-03-02 | 03-03 | Milanova Tsveta | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 1.2K | 28.96 | 34K | 41.6K | SEC |
| 2026-03-02 | 03-03 | Milanova Tsveta | Chief Commercial Officer | M 選擇權執行 | 4.0K | – | – | 42.8K | SEC |
| 2026-03-02 | 03-03 | Milanova Tsveta | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 1.7K | 28.96 | 49K | 38.8K | SEC |
| 2026-03-02 | 03-03 | Gheuens Sarah | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.2K | 28.96 | 34K | 74.4K | SEC |
| 2026-03-02 | 03-03 | Milanova Tsveta | Chief Commercial Officer | M 選擇權執行 | 5.7K | – | – | 40.5K | SEC |
| 2026-03-02 | 03-03 | Washburn Theodore James Jr. | Principal Accounting Officer | M 選擇權執行 | 2.4K | – | – | 3.3K | SEC |
| 2026-03-02 | 03-03 | Washburn Theodore James Jr. | Principal Accounting Officer | S 公開市場賣出(10b5-1) | 798 | 28.96 | 23K | 6.1K | SEC |
| 2026-03-02 | 03-03 | Burns James William | Chief Legal Officer | S 公開市場賣出(10b5-1) | 1.7K | 28.96 | 49K | 38.5K | SEC |
| 2026-03-02 | 03-03 | Washburn Theodore James Jr. | Principal Accounting Officer | M 選擇權執行 | 2.7K | – | – | 6.9K | SEC |
| 2026-03-02 | 03-03 | Washburn Theodore James Jr. | Principal Accounting Officer | S 公開市場賣出(10b5-1) | 727 | 28.96 | 21K | 4.2K | SEC |
| 2026-03-02 | 03-03 | Goff Brian | Chief Executive Officer | S 公開市場賣出(10b5-1) | 5.9K | 28.96 | 171K | 165K | SEC |
| 2026-03-02 | 03-03 | Burns James William | Chief Legal Officer | S 公開市場賣出(10b5-1) | 1.2K | 28.96 | 34K | 44.1K | SEC |
| 2026-03-02 | 03-03 | Washburn Theodore James Jr. | Principal Accounting Officer | M 選擇權執行 | 2.5K | – | – | 5.0K | SEC |
| 2026-03-02 | 03-03 | Goff Brian | Chief Executive Officer | S 公開市場賣出(10b5-1) | 8.3K | 28.96 | 239K | 157K | SEC |
| 2026-03-02 | 03-03 | Goff Brian | Chief Executive Officer | M 選擇權執行 | 18.0K | – | – | 166K | SEC |
| 2026-03-02 | 03-03 | Goff Brian | Chief Executive Officer | S 公開市場賣出(10b5-1) | 3.9K | 28.96 | 112K | 148K | SEC |
| 2026-03-02 | 03-03 | Goff Brian | Chief Executive Officer | M 選擇權執行 | 8.5K | – | – | 152K | SEC |
| 2026-03-02 | 03-03 | Washburn Theodore James Jr. | Principal Accounting Officer | S 公開市場賣出(10b5-1) | 698 | 28.96 | 20K | 2.6K | SEC |
| 2026-03-02 | 03-03 | Goff Brian | Chief Executive Officer | M 選擇權執行 | 13.0K | – | – | 170K | SEC |
| 2026-01-05 | 01-07 | Milanova Tsveta | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 2.9K | 27.02 | 78K | 34.8K | SEC |
| 2026-01-05 | 01-07 | Milanova Tsveta | Chief Commercial Officer | M 選擇權執行 | 8.5K | – | – | 37.7K | SEC |
| 2025-12-30 | 01-02 | Goff Brian | Chief Executive Officer | M 選擇權執行 | 12.8K | – | – | 149K | SEC |
| 2025-12-30 | 01-02 | Goff Brian | Chief Executive Officer | M 選擇權執行 | 25.5K | – | – | 149K | SEC |
| 2025-12-30 | 01-02 | Gheuens Sarah | Chief Medical Officer | S 公開市場賣出(10b5-1) | 2.9K | 27.09 | 79K | 64.8K | SEC |
| 2025-12-30 | 01-02 | Gheuens Sarah | Chief Medical Officer | M 選擇權執行 | 6.0K | – | – | 67.7K | SEC |
| 2025-12-30 | 01-02 | Milanova Tsveta | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 2.9K | 27.09 | 79K | 29.2K | SEC |
| 2025-12-30 | 01-02 | Milanova Tsveta | Chief Commercial Officer | M 選擇權執行 | 6.0K | – | – | 32.1K | SEC |
| 2025-12-30 | 01-02 | Goff Brian | Chief Executive Officer | S 公開市場賣出(10b5-1) | 12.5K | 27.09 | 338K | 137K | SEC |
| 2025-12-30 | 01-02 | Jones Cecilia | Chief Financial Officer | S 公開市場賣出(10b5-1) | 2.9K | 27.09 | 79K | 37.4K | SEC |
| 2025-12-30 | 01-02 | Jones Cecilia | Chief Financial Officer | M 選擇權執行 | 6.0K | – | – | 40.3K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 6.5M | 240M | 新進 | 新進 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 5.9M | 220M | 新進 | 新進 |
| STATE STREET CORP | 3.5M | 131M | 新進 | 新進 |
| Lynx1 Capital Management LP | 3.4M | 127M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 3.1M | 115M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.9M | 108M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.7M | 99.5M | 新進 | 新進 |
| ARMISTICE CAPITAL, LLC | 2.4M | 89.1M | 新進 | 新進 |
| Erste Asset Management GmbH | 2.2M | 82.0M | 新進 | 新進 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2.1M | 78.3M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6M | 58.4M | 新進 | 新進 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.4M | 51.0M | 新進 | 新進 |
| ADAR1 Capital Management, LLC | 1.3M | 47.8M | 新進 | 新進 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.3M | 47.5M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 1.2M | 46.3M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 1.2M | 42.7M | 新進 | 新進 |
| UBS Group AG | 986K | 36.6M | 新進 | 新進 |
| MORGAN STANLEY | 963K | 35.7M | 新進 | 新進 |
| Nuveen, LLC | 874K | 32.4M | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 811K | 30.1M | 新進 | 新進 |
| Foresite Capital Management VI LLC | 785K | 29.1M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 733K | 27.2M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 684K | 25.4M | 新進 | 新進 |
| Parkman Healthcare Partners LLC | 669K | 24.8M | 新進 | 新進 |
| SCS Capital Management LLC | 613K | 22.7M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 238 +4 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 238 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 66.1M · 100.0% |
| 合計季末市值 | 2.4B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 7.5M |
|---|---|
| 與上期比 | -1.2% |
| 佔流通股數 | 12.62% |
| 日均成交量 | 893K |
| 回補天數 | 8.4 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 7.5M | -1.2% | 12.62% | 893K | 8.4 |
| 2026-08-14 | 7.6M | +11.5% | 12.78% | 1.1M | 7.0 |
| 2026-07-31 | 6.8M | +3.2% | 11.46% | 1.3M | 5.1 |
| 2026-07-15 | 6.6M | -1.9% | 11.11% | 1.0M | 6.4 |
| 2026-06-30 | 6.8M | -2.1% | 11.32% | 1.3M | 5.1 |
| 2026-06-15 | 6.9M | -0.4% | 11.55% | 1.0M | 6.6 |
| 2026-05-29 | 6.9M | -7.0% | 11.60% | 849K | 8.2 |
| 2026-05-15 | 7.5M | +6.8% | 12.48% | 859K | 8.7 |
| 2026-04-30 | 7.0M | -1.5% | 11.68% | 1.7M | 4.2 |
| 2026-04-15 | 7.1M | +7.2% | 11.86% | 1.0M | 7.0 |
| 2026-03-31 | 6.6M | +6.7% | 11.07% | 1.0M | 6.4 |
| 2026-03-13 | 6.2M | -0.8% | 10.37% | 756K | 8.2 |
| 2026-02-27 | 6.2M | -1.4% | 10.45% | 728K | 8.6 |
| 2026-02-13 | 6.3M | -6.0% | 10.60% | 888K | 7.1 |
| 2026-01-30 | 6.7M | -9.7% | 11.27% | 926K | 7.3 |
| 2026-01-15 | 7.4M | +5.1% | 12.48% | 952K | 7.8 |
| 2025-12-31 | 7.1M | +15.7% | 11.88% | 2.0M | 3.6 |
| 2025-12-15 | 6.1M | +12.1% | 10.26% | 1.3M | 4.8 |
| 2025-11-28 | 5.5M | +26.2% | 9.16% | 4.2M | 1.3 |
| 2025-11-14 | 4.3M | -5.9% | 7.26% | 611K | 7.1 |
| 2025-10-31 | 4.6M | -7.5% | 7.71% | 594K | 7.8 |
| 2025-10-15 | 5.0M | -4.0% | 8.33% | 496K | 10.0 |
| 2025-09-30 | 5.2M | +9.4% | 8.68% | 632K | 8.2 |
| 2025-09-15 | 4.7M | -0.6% | 7.93% | 972K | 4.9 |
| 2025-08-29 | 4.8M | -1.1% | 7.98% | 586K | 8.1 |
| 2025-08-15 | 4.8M | +17.4% | 8.07% | 1.2M | 4.0 |